Conference abstract · 4 Aug 2016
Conference abstract
Stem cell therapy for bleeding disorder
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hemophilia A is an X-linked recessive bleeding disorder caused by the deficiency the clotting Factor V-III. Currently, treatment of hemophilia consists of factor replacement using fresh frozen plasma, cryoprecipitate, or Factor VIII concentrate. The transdifferentiation of bone marrow cells (BMCs) into hepatocytes has created enormous interest in applying this process to the development of cellular medicine for degenerative and genetic diseases. The cellular origin of factor VIII synthesis is controversial. Liver transplantation cures hemophilia A, demonstrating that the liver is a major site of factor VIII synthesis. We hypothesize that the partial replacement of mutated liver cells by healthy cells in hemophilia A (HA) mice could ameliorate the severity of the bleeding disorder. We perturbed the host liver with acetaminophen to facilitate the engraftment and hepatic differentiation of lineage- depleted (Lin - ) enhanced green fluorescent protein (eGFP)-expressing BMCs. Immunohistochemistry experiments with the liver tissue showed that the donor- derived cells expressed the markers of both hepatocytes (albumin and cytokeratin-18) and endothelial cells (von Willbrand factor). The results of fluorescent in situ hybridization and immunocytochemistry experiments suggested that differentiation was direct in this model. The BMC-recipient mice expressed FVIII protein and survived in a tail clip challenge experiment. Furthermore, a coagulation assay confirmed that the plasma FVIII activity was maintained at 20.4 ? 3.6% of normal pooled plasma activity for more than a year without forming its inhibitor. Overall, this report demonstrated that BMCs rescued the bleeding phenotype in HA mice, suggesting a potential therapy for this and other related disorders.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Clinical results of Stem Cell Therapy in Neurological Disorders
Conference abstract · 23 Mar 2015
Neuron point-of-care stem cell therapy (N-POCST): Transplantation of autologous bone marrow-derived stem cells for traumatic central nervous system disorders, the future of a new method
Perspective · 29 Apr 2024
Optimized Stem Cell-Based Therapies for Rare Disorders
Conference abstract · 14 Mar 2019
Stem cell therapy for autism spectrum disorder
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Article · 2 Jun 2026
Stem Cell Therapy for Diabetes Mellitus: Exploring Cellular Approaches for Pancreatic Regeneration
Article · 2 Jun 2026
Stem Cell Banking and Preservation: Advancing Future Therapeutic Possibilities through Cellular Storage
Article · 2 Jun 2026
Stem Cells in Cardiovascular Regeneration: Emerging Strategies for Heart Repair and Functional Recovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Neelam Yadav”
- BylineArticles whose byline prints “Sumod K”
- BylineArticles whose byline prints “Ashutosh Halder”
- BylineArticles whose byline prints “Renu Saxena”
- BylineArticles whose byline prints “Asok Mukhopadhyay”

